EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ginger-Derived Nanoparticles Deliver a VEGFA-Targeting DNAzyme and Modulate Retinal VEGFA Expression and Inflammatory Markers in Experimental Diabetic Retinopathy

Tong Wang iD, Yupeng Zhang, Jian Cao iD, Jing Li, Yunxiang Chao, Wen Yang, Xiaoxiao Jin, Zhipeng You iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s627904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Tong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, People's Republic …. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Diabetic Retinopathy, DNA, Catalytic, Nanoparticles. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To address the limitations of current anti-vascular endothelial growth factor (anti-VEGF) therapies for diabetic retinopathy (DR), which do not effectively inhibit VEGFA synthesis at the genetic source and provide only marginal improvements in the chronic inflammatory microenvironment, this study employs ginger-derived nanoparticles (GDNPs) to create a deoxyribozyme (DNAzyme) delivery system (GDNPs@Dz) targeting VEGFA mRNA. It further investigates the combined effects of this system on gene silencing and anti-inflammatory activity in an experimental setting.

Methods

GDNPs were isolated from fresh ginger using differential centrifugation followed by size-exclusion chromatography purification, and their physicochemical properties and biosafety were characterized. Phosphorothioate-modified 10-23 DNAzyme was incorporated into GDNPs via ultrasonication. The uptake of GDNPs@Dz by human retinal microvascular endothelial cells was evaluated in vitro, alongside its inhibitory effects on cell migration and tube formation. In a streptozotocin-induced DR mouse model, the study assessed the intraocular retention of the AF647-labeled DNAzyme signal, VEGFA expression, and inflammatory markers (IL-1β, TNF-α) following a single intravitreal injection (2 μL/eye, 39 pmol DNAzyme + 4 μg GDNPs). Treatment doses in vitro were 500 nM free DNAzyme, 50 μg/mL empty GDNPs, or an equivalent combination. All in vitro experiments were performed in three independent biological replicates, with three technical replicates per condition, and in vivo analyses used n = 3 animals per group per time point, with VEGFA expression assessed at days 3, 7, 10, 14, and 21.

Results

GDNPs@Dz was internalized by retinal microvascular endothelial cells and reduced high glucose-induced cell migration and tube formation in vitro. In the diabetic mouse model, GDNPs@Dz prolonged the ocular retention of the AF647-labeled DNAzyme signal compared with free DNAzyme and reduced retinal VEGFA mRNA for up to two weeks after a single injection. Representative immunofluorescence showed reduced IL-1β and TNF-α positive signals after empty GDNPs treatment. These findings indicate a combined effect of gene silencing and anti-inflammatory activity.

Conclusion

This preclinical proof-of-concept study demonstrates that ginger-derived nanoparticles can deliver a VEGFA-targeting DNAzyme and modulate retinal VEGFA expression and inflammatory markers in an experimental diabetic setting. The system showed a favorable biosafety profile and combined gene-silencing and anti-inflammatory activity, providing a basis for further preclinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor ADiabetic RetinopathyDNA, CatalyticNanoparticlesZingiber officinaleAnimalsHumansMiceMaleRetinaMice, Inbred C57BLCell MovementEndothelial Cells

Stichwörter der Autor:innen

DNAzymeVEGFAanti-inflammatorydiabetic retinopathyginger exosome-like nanoparticles

Substanzen

Vascular Endothelial Growth Factor ADNA, Catalytic

Autor:innen und Institutionen

  • Department of Ophthalmology, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, People's Republic of China.

ORCID-Profile: Tong Wang, Jian Cao, Zhipeng You

Zitieren

APA

Wang, T., Zhang, Y., Cao, J., Li, J., Chao, Y., Yang, W., Jin, X., & You, Z. (2026). Ginger-Derived Nanoparticles Deliver a VEGFA-Targeting DNAzyme and Modulate Retinal VEGFA Expression and Inflammatory Markers in Experimental Diabetic Retinopathy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s627904

Vancouver

Wang T, Zhang Y, Cao J, Li J, Chao Y, Yang W, et al. Ginger-Derived Nanoparticles Deliver a VEGFA-Targeting DNAzyme and Modulate Retinal VEGFA Expression and Inflammatory Markers in Experimental Diabetic Retinopathy. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s627904

BibTeX
@article{Wang2026,
  author = {Wang, Tong and Zhang, Yupeng and Cao, Jian and Li, Jing and Chao, Yunxiang and Yang, Wen and Jin, Xiaoxiao and You, Zhipeng},
  title = {Ginger-Derived Nanoparticles Deliver a VEGFA-Targeting DNAzyme and Modulate Retinal VEGFA Expression and Inflammatory Markers in Experimental Diabetic Retinopathy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s627904}
}
Kostenlos starten →